Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
991 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00900627 | Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)(THYME) | completed | Phase 1 / Phase 2 | 330 | AstraZenecaINDUSTRY | 14 | Jan 20, 2016 | clinicaltrials |
| NCT00681122 | CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)(CARIATIDE) | completed | — | 2,600 | AstraZenecaINDUSTRY | 18 |
| Jan 18, 2016 |
| clinicaltrials |
| NCT01162395 | Open Label Prostate Cancer Study | completed | Phase 1 | 64 | AstraZenecaINDUSTRY | 3 | Jan 12, 2016 | clinicaltrials |
| NCT01561443 | LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer(LINE) | completed | — | 153 | AstraZenecaINDUSTRY | 1 | Jan 11, 2016 | clinicaltrials |
| NCT02056392 | To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers | completed | Phase 1 | 54 | AstraZenecaINDUSTRY | 1 | Nov 9, 2015 | clinicaltrials |
| NCT01588548 | Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma | completed | Phase 1 | 43 | AstraZenecaINDUSTRY | 2 | Nov 4, 2015 | clinicaltrials |
| NCT01872078 | A Study of AZD4901 in Females With Polycystic Ovary Syndrome | completed | Phase 2 | 67 | AstraZenecaINDUSTRY | 3 | Oct 12, 2015 | clinicaltrials |
| NCT00229697 | Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study | completed | Phase 2 | 317 | AstraZenecaINDUSTRY | 12 | Oct 5, 2015 | clinicaltrials |
| NCT01489722 | Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients | terminated | Phase 1 | 55 | AstraZenecaINDUSTRY | 2 | Aug 11, 2015 | clinicaltrials |
| NCT02405247 | TAURAS - T790 AURA ScreenFailure SOC Registry Study(TAURAS) | terminated | — | 400 | AstraZenecaINDUSTRY | 2 | Jul 31, 2015 | clinicaltrials |
| NCT01928953 | Longitudinal Study of Patients With Opioid-Induced Constipation | completed | — | 520 | AstraZenecaINDUSTRY | 2 | Jul 8, 2015 | clinicaltrials |
| NCT02368990 | T790M Mutation Positive 2nd Line STandard of cAre Registry(T-STAR) | withdrawn | — | 0 | AstraZenecaINDUSTRY | 9 | Jul 8, 2015 | clinicaltrials |
| NCT01931761 | Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers | completed | Phase 1 | 6 | AstraZenecaINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT02063204 | To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects | completed | Phase 1 | 24 | AstraZenecaINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT02093728 | To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers | completed | Phase 1 | 26 | AstraZenecaINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT01323790 | Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation | completed | Phase 3 | 700 | AstraZenecaINDUSTRY | 8 | Jun 2, 2015 | clinicaltrials |
| NCT01309841 | Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation | completed | Phase 3 | 652 | AstraZenecaINDUSTRY | 4 | Jun 1, 2015 | clinicaltrials |
| NCT01384292 | Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain | terminated | Phase 3 | 14 | AstraZenecaINDUSTRY | 14 | Jun 1, 2015 | clinicaltrials |
| NCT01069835 | Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)(EPICLIN) | completed | — | 840 | AstraZenecaINDUSTRY | 1 | May 19, 2015 | clinicaltrials |
| NCT01300351 | Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women | completed | Phase 3 | 249 | AstraZenecaINDUSTRY | 1 | Apr 24, 2015 | clinicaltrials |
| NCT00065325 | The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer(EFECT) | completed | Phase 3 | 694 | AstraZenecaINDUSTRY | 15 | Feb 24, 2015 | clinicaltrials |
| NCT00846976 | Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer | completed | Phase 3 | 101 | AstraZenecaINDUSTRY | 1 | Jan 21, 2015 | clinicaltrials |
| NCT00710268 | Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours | completed | Phase 1 | 18 | AstraZenecaINDUSTRY | 1 | Jan 14, 2015 | clinicaltrials |
| NCT01303692 | Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent | completed | — | 312 | AstraZenecaINDUSTRY | 1 | Jan 14, 2015 | clinicaltrials |
| NCT01123434 | Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients. | completed | — | 200 | AstraZenecaINDUSTRY | 1 | Jan 8, 2015 | clinicaltrials |
| NCT01340040 | Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects | completed | Phase 1 | 10 | AstraZenecaINDUSTRY | 1 | Dec 11, 2014 | clinicaltrials |
| NCT01336205 | Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation | completed | Phase 3 | 844 | AstraZenecaINDUSTRY | 1 | Oct 20, 2014 | clinicaltrials |
| NCT00860561 | Faslodex Post Marketing Surveillance | completed | — | 42 | AstraZenecaINDUSTRY | 1 | Oct 10, 2014 | clinicaltrials |
| NCT01579578 | Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer | terminated | Phase 2 | 39 | AstraZenecaINDUSTRY | 5 | Sep 12, 2014 | clinicaltrials |
| NCT01499303 | Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer | completed | Phase 2 | 101 | AstraZenecaINDUSTRY | 2 | Aug 22, 2014 | clinicaltrials |
| NCT00338130 | Randomised Study to Compare the Efficacy of AZD6244 vs TMZ | completed | Phase 2 | 239 | AstraZenecaINDUSTRY | 10 | Aug 13, 2014 | clinicaltrials |
| NCT00372788 | AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen | completed | Phase 2 | 88 | AstraZenecaINDUSTRY | 3 | Aug 13, 2014 | clinicaltrials |
| NCT00372944 | AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy | completed | Phase 2 | 70 | AstraZenecaINDUSTRY | 5 | Aug 13, 2014 | clinicaltrials |
| NCT00514761 | Phase II Efficacy Study of AZD6244 in Colorectal Cancer | completed | Phase 2 | 64 | AstraZenecaINDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT00710515 | Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 2 | Aug 13, 2014 | clinicaltrials |
| NCT01974349 | To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers | completed | Phase 1 | 39 | AstraZenecaINDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT01151215 | Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer(MINT) | terminated | Phase 2 | 482 | AstraZenecaINDUSTRY | 18 | Jul 25, 2014 | clinicaltrials |
| NCT00077025 | Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer | completed | Phase 2 | 174 | AstraZenecaINDUSTRY | 4 | Jul 16, 2014 | clinicaltrials |
| NCT00621725 | Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours | completed | Phase 1 | 36 | AstraZenecaINDUSTRY | 2 | Jul 15, 2014 | clinicaltrials |
| NCT01003158 | Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. | completed | Phase 1 | 17 | AstraZenecaINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01692262 | Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.(PYRUS) | completed | Phase 1 | 59 | AstraZenecaINDUSTRY | 2 | Jun 19, 2014 | clinicaltrials |
| NCT01955668 | AZD6738 First Time in Patient Multiple Ascending Dose Study | completed | Phase 1 | 2 | AstraZenecaINDUSTRY | 1 | Jun 19, 2014 | clinicaltrials |
| NCT01960374 | Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PK | completed | Phase 1 | 117 | AstraZenecaINDUSTRY | 1 | Jun 2, 2014 | clinicaltrials |
| NCT02046850 | To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers | completed | Phase 1 | 24 | AstraZenecaINDUSTRY | 1 | Apr 29, 2014 | clinicaltrials |
| NCT01434485 | Nexium Capsules Clinical Experience Investigation | completed | — | 3,691 | AstraZenecaINDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01435525 | Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation | completed | — | 369 | AstraZenecaINDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01525199 | Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.(IDENTIFY) | completed | — | 450 | AstraZenecaINDUSTRY | 1 | Apr 14, 2014 | clinicaltrials |
| NCT00494221 | A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX | completed | Phase 1 / Phase 2 | 172 | AstraZenecaINDUSTRY | 1 | Mar 27, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials